Ken: Keep thinking. Being the tireless researcher that you are, I'm confident that we would all be both curious and grateful for any plausible explanations for this once in a decade shorting phenomenon of GSK stock that Buddyboy has brought to our attention. I apologize for for presuming on your good nature and dedication to the board, but your skill set in investigative matters is beyond challenge.

Best regards,

Jake